Skip to main content
Will the launch of Favipiravir mark the turnaround for Glenmark Pharma? - Economic Times 22-Jun-2020

Will the launch of Favipiravir mark the turnaround for Glenmark Pharma? - Economic Times
If the drug proves to be efficacious for Covid treatment, Glenmark will cash in on first mover advantage.
More...